I-Sitagliptin Triazole Hydrochloride CAS 762240-92-6 Ubunyulu >99.0% (HPLC) Umzi-mveliso oPhezulu oPhezulu
Ubonelelo ngeSitagliptin Phosphate Monohydrate Eziyeleleneyo neziPhakathi:
I-Sitagliptin API CAS 486460-32-6
I-Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
I-Sitagliptin Triazole Hydrochloride CAS 762240-92-6
I-Sitagliptin Phosphate Monohydrate ePhakathi CAS 486460-21-3
Igama leMchiza | 3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride |
Izithethantonye | iSitagliptin Triazole Hydrochloride;ISitagliptin ePhakathi A |
Inombolo yeCAS | 762240-92-6 |
Inombolo yeCAT | RF-PI1193 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C6H7F3N4·HCl |
Ubunzima beMolekyuli | 228.60 |
Indawo yokunyibilika | 236.0 ~ 246.0℃ |
Ukunyibilika | Inyibilika kwiMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe-Mhlophe wePowder |
Ukuchongwa yi-HPLC | Ixesha lokugcinwa kwesampulu lihambelana nomgangatho wereferensi |
Ukuchongwa nge-IR | Iyahambelana |
Ilahleko ekomisweni | <0.50% |
Izinto ezinxulumeneyo | |
Nakuphi na Ukungacoceki Okukodwa | <0.50% |
Ukungcola ngokupheleleyo | <1.00% |
Iintsimbi ezinzima | <20ppm |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi weSitagliptin Phosphate Monohydrate (CAS: 654671-77-9) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride (CAS: 762240-92-6) iphakathi kweSitagliptin Phosphate Monohydrate ( I-CAS: 654671-77-9), eyi-oral-bioavailable selective DPP4 inhibitor efunyenwe ngokulungiswa kweklasi ye-β-aminoacid-derived DPP4 inhibitors.Yehlisa umsebenzi we-DPP4 ngendlela ezinzileyo elandela ulawulo kube kanye yonke imihla, igcina amanqanaba ajikelezayo e-GIP engaguqukiyo kunye ne-GLP1 emva kokutya kwizifundo ezibukhali nezingapheliyo kwaye yehlisa amanqanaba eglucose yegazi ngaphandle kokunyuka okubonakalayo kwe-hypoglycaemia.I-Sitagliptin Phosphate (STG) isetyenziselwa ukuphatha uhlobo lwe-DM ye-2 kuba iphucula ulawulo lwe-glycemic ngokunyusa amanqanaba e-hormone ye-incretin esebenzayo, i-GLP-1 (peptide-1) kunye ne-GIP (i-glucose-exhomekeke kwi-insulinotropic peptide).I-STG yavunywa yi-FDA kwi-2006.